Genetic Testing to Understand and Address Renal Disease Disparities Across the United States

NACompletedINTERVENTIONAL
Enrollment

6,789

Participants

Timeline

Start Date

July 10, 2020

Primary Completion Date

April 9, 2024

Study Completion Date

May 17, 2024

Conditions
Chronic Kidney DiseaseHypertension
Interventions
OTHER

Timing of return of results

Participants will be randomized to immediate versus delayed APOL1 return of results

Trial Locations (14)

10029

Icahn School of Medicine at Mount Sinai, New York

10035

The Institute for Family Health, New York

15261

University of Pittsburgh, Pittsburgh

28358

Southeastern Healthcare, Lumberton

32209

University of Florida - Jacksonville, Jacksonville

32610

University of Florida - Gainesville, Gainesville

35294

University of Alabama at Birmingham, Birmingham

37208

Meharry Medical College, Nashville

Nashville General Hospital, Nashville

37232

Vanderbilt University Medical Center, Nashville

46202

Eskenazi Health, Indianapolis

Indiana University, Indianapolis

70112

University Medical Center New Orleans, New Orleans

75210

Baylor Research Institute, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Human Genome Research Institute (NHGRI)

NIH

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

University of Florida

OTHER

collaborator

Indiana University School of Medicine

OTHER

collaborator

Vanderbilt University Medical Center

OTHER

lead

Duke University

OTHER